Active substances
Hyaluronate + Lidocaine
- SFDA 7
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| DERMALSTYLE forte Lidocaine | 23,0.3 mg/ml,mg/ml | Gel for injection · Subcutaneous use | 1 Pre-filled syringe | SAR 342.35 | Generic · Prescription | CROMA PHARMA Gmbh | Valid |
| DERMALSTYLE smile Lidocaine | 23,0.3 mg/ml,mg/ml | Gel for injection · Subcutaneous use | 1 Pre-filled syringe | SAR 342.35 | Generic · Prescription | CROMA PHARMA Gmbh | Valid |
| ART FILLER FINE LINES | 20,3 mg/ml,mg/ml | Solution for injection · Intradermal use | 2 Pre-filled syringe | SAR 530.90 | Generic · Prescription | FILLMED MANUFACTURING | Withdrawn by MAH · Not Marketed |
| ART FILLER UNIVERSAL | 25,3 mg/ml,mg/ml | Solution for injection · Intradermal use | 2 Pre-filled syringe | SAR 725.05 | Generic · Prescription | FILLMED MANUFACTURING | Withdrawn by MAH · Not Marketed |
| ART FILLER VOLUME | 25,3 mg/ml,mg/ml | Solution for injection · Intradermal use | 2 Pre-filled syringe | SAR 758.40 | Generic · Prescription | FILLMED MANUFACTURING | Withdrawn by MAH · Not Marketed |
| ART FILLER VOLUME | 25,3 mg/ml,mg/ml | Solution for injection · Intradermal use | 2 Pre-filled syringe | SAR 707.85 | Generic · Prescription | FILLMED MANUFACTURING | Withdrawn by MAH · Not Marketed |
| Juvederm Volux | 25 , 3 mg | Gel for injection · Intradermal use | 1 Pre-filled syringe | SAR 1383.84 | Generic · Prescription | ALLERGAN | Withdrawn by MAH · Not Marketed |
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.